This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (74)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles E. Cherubin, MD

Arch Intern Med. 1971;128(2):309-313.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

With the recent widespread increase in narcotic addiction, we as physicians are professionally responsible for the medical care of the increasing number of addicts whom we see in hospitals or in private practice; no one can now justifiably feel himself isolated from treating such patients. Further, they suffer from a high incidence of infrequent or rare infectious diseases and offer the researcher an unusual opportunity to study the disease mechanisms and therapy.

There is a decidedly increased mortality among addicts.¹ In New York the principal cause of death appears to be a syndrome of sudden collapse accompanied by pulmonary edema subsequent to an intravenous injection.²

Other conditions associated with narcotic usage are such infectious disease as tetanus, septicemia, hepatitis, an unknown type of chronic liver disease, endocarditis, and superficial abscesses.^1,3,4 We no longer see in this city the malaria which was at one time the most widely . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Department of Medicine, New York Medical College and the Office of the Hospital Epidemiologist, Harlem Hospital Center, New York.

Footnotes
Received for publication Jan 7, 1971; accepted April 27.

Reprint requests to Department of Medicine, Metropolitan Hospital, 97th St & 1st Ave, New York 10029 (Dr. Cherubin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?